LIMKi 3

Name	LIMKi 3
Supplier	R&D Systems
Catalog	4745
Prices	$199.00
Sizes	10 mg
Cas Number	1338247-35-0
Chemical Name	N-[5-[1-(2,6-Dichlorophenyl)-3-(difluoromethyl)-1H-pyrazol-5-yl]-2-thiazolyl]-2-methylpropanamide
Formula	C17H14Cl2F2N4OS
Molecular Weight	431.29
Purity	>98%
Supplier Page	Shop

Product References

The actin-severing protein cofilin is downstream of neuregulin signaling and is - The actin-severing protein cofilin is downstream of neuregulin signaling and is

Sparrow N, Manetti ME, Bott M, Fabianac T, Petrilli A, Bates ML, Bunge MB, Lambert S, Fernandez-Valle C. J Neurosci. 2012 Apr 11;32(15):5284-97.

Identification of a nonkinase target mediating cytotoxicity of novel kinase - Identification of a nonkinase target mediating cytotoxicity of novel kinase

Ross-Macdonald P, de Silva H, Guo Q, Xiao H, Hung CY, Penhallow B, Markwalder J, He L, Attar RM, Lin TA, Seitz S, Tilford C, Wardwell-Swanson J, Jackson D. Mol Cancer Ther. 2008 Nov;7(11):3490-8.

LIM kinases are required for invasive path generation by tumor and - LIM kinases are required for invasive path generation by tumor and

Scott RW, Hooper S, Crighton D, Li A, Konig I, Munro J, Trivier E, Wickman G, Morin P, Croft DR, Dawson J, Machesky L, Anderson KI, Sahai EA, Olson MF. J Cell Biol. 2010 Oct 4;191(1):169-85.